Literature DB >> 19122130

Early-onset versus late-onset HIV-related secondary mania in Uganda.

Etheldreda Nakimuli-Mpungu1, Seggane Musisi, Steven Kiwuwa Mpungu, Elly Katabira.   

Abstract

BACKGROUND: First-episode secondary mania in human immunodeficiency virus (HIV) infection has been described among samples of predominantly Caucasian, HIV-positive male patients in developed countries.
OBJECTIVE: The goal of this study was to compare the demographic and clinical characteristics of HIV-positive patients with early-onset and late-onset first-episode secondary mania in HIV infection. There were previous findings of an association between late-onset mania and severe cognitive impairment.
METHOD: Subjects were HIV inpatients with clinically-confirmed mania, who received standard demographic, psychiatric, physical, and laboratory assessments. Early-onset patients had CD4 cell counts > 200 mm(3); late-onset patients had CD4 cell counts < or = 200 mm(3).
RESULTS: There were no demographic or cognitive differences between early-onset and late-onset mania patients, and high rates of psychotic symptoms in both groups. However, late-onset patients had more manic symptoms.
CONCLUSION: Late-onset HIV mania patients had more severe psychopathology and, thus, demonstrated a greater need for highly active retroviral therapy.

Entities:  

Mesh:

Year:  2008        PMID: 19122130     DOI: 10.1176/appi.psy.49.6.530

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  8 in total

1.  Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.

Authors:  Etheldreda Nakimuli-Mpungu; Brian Mutamba; Makanga Othengo; Seggane Musisi
Journal:  Afr Health Sci       Date:  2009-08-01       Impact factor: 0.927

Review 2.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

3.  Altered lipid concentrations of liver, heart and plasma but not brain in HIV-1 transgenic rats.

Authors:  Ameer Y Taha; Mireille Basselin; Epolia Ramadan; Hiren R Modi; Stanley I Rapoport; Yewon Cheon
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-08-29       Impact factor: 4.006

Review 4.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

5.  Cognitive dysfunction among HIV positive and HIV negative patients with psychosis in Uganda.

Authors:  Noeline Nakasujja; Peter Allebeck; Hans Agren; Seggane Musisi; Elly Katabira
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

6.  Effect of HIV infection on time to recovery from an acute manic episode.

Authors:  E Nakimuli-Mpungu; B Mutamba; S Nshemerirwe; Ms Kiwuwa; S Musisi
Journal:  HIV AIDS (Auckl)       Date:  2010-09-29

7.  Sub-optimal vitamin B-12 levels among ART-naïve HIV-positive individuals in an urban cohort in Uganda.

Authors:  Aggrey S Semeere; Damalie Nakanjako; Henry Ddungu; Andrew Kambugu; Yukari C Manabe; Robert Colebunders
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

8.  Psychiatric Manifestations in a Patient with HIV-Associated Neurocognitive Symptoms and Cryptococcal Meningitis.

Authors:  Prabhakar C Holikatti; Nilamadhab Kar
Journal:  Indian J Psychol Med       Date:  2012-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.